ArticleBMC public health2026
The dynamics of rapid stunting reduction among children under 5 : a comparative study of age-specific trajectories and wealth disparities across six high-performing countries using JME and DHS data.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildhood stunting remains a premier global public health challenge, with progress recently plateauing. Despite this, certain 'Success Outliers' defined in this study as nations that have achieved an Average Annual Rate of Reduction (AARR) ≥ 4.0% demonstrate that accelerated progress is achievable even in high-burden contexts.
objectivesThe primary objectives of this study are (1) to evaluate the global association between initial stunting burden and the velocity of progress, measured by the Average Annual Rate of Reduction (AARR); (2) to characterize temporal shifts in age-specific growth dynamics among 'Success Outlier' nations defined here as those achieving an AARR ≥ 4.0%; and (3) to measure the evolution of wealth-based stunting inequalities using the Concentration Index.
methodsThis study analyzed six 'Success Outlier' nations - Albania, Armenia, Bolivia, Peru, Tajikistan, and Turkey; selected based on an Average Annual Rate of Reduction (AARR) ≥ 4.0%. The analysis utilized a pooled dataset of 142,028 children from Demographic and Health Surveys (1992-2023). We employed non-parametric Kernel-weighted local-mean regressions (lpoly) to estimate age-specific stunting trajectories and calculated the Concentration Index (CI) to evaluate longitudinal shifts in socioeconomic inequality.
resultsThe six selected "Success Outliers" achieved an Actual Annual Average Rate of Reduction (AARR) ≥ 4.0%, led by Albania (6.3%) and Turkey (5.54%), which significantly outperformed the global median AARR of 2.24%. High-resolution analysis shows Peru reduced peak stunting from nearly 50% in 1992 to approximately 20% by 2012 by flattening the growth failure curve between 6 and 24 months. Socioeconomic equity improved most notably in Peru, where the Concentration Index (CI) shifted from - 0.312 to - 0.214, and Turkey, where it moved from - 0.285 to - 0.182.
conclusionsAccelerated stunting reduction is fundamentally characterized by a "vertical upward shift" in the entire age-specific growth distribution. While the "first 1000 days" remains a vital window, sustaining high reduction velocities requires nutritional and environmental support that extends into the third year of life to prevent the persistent "deep dip" seen in stagnant contexts. Furthermore, the stability of the Concentration Index in "Success Outlier" nations suggests that rapid progress is only achievable when child growth is structurally decoupled from socioeconomic status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.